SCHEMBL30962897

SCHEMBL30962897

COc1nc(Nc2ccc(C3CCN(C)CC3)c(C)c2)ncc1C(=O)Nc1c(C)ccc(O)c1C

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SIK1 P57059 2/20 0.47
▸ SIK2 Q9H0K1 2/20 0.47
▸ SIK3 Q9Y2K2 2/20 0.47
▸ LCK P06239 7/20 0.46
▸ KDR P35968 3/20 0.45
▸ MAPK14 Q16539 3/20 0.45
▸ JAK3 P52333 2/20 0.45
▸ TEK Q02763 1/20 0.45
▸ WEE1 P30291 1/20 0.44
▸ TNK2 Q07912 2/20 0.41
▸ BTK Q06187 1/20 0.41
▸ TTK P33981 1/20 0.41
▸ SRC P12931 3/20 0.40
▸ ALK Q9UM73 1/20 0.39
▸ BRD4 O60885 1/20 0.39
▸ CDK1 P06493 1/20 0.39
▸ CDK2 P24941 1/20 0.39
▸ JAK2 O60674 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30962812 0.93 WEE1 (0.47) SIK1SIK2SIK3LCKKDR
SCHEMBL30962850 0.89 SIK1 (0.48) SIK1SIK2SIK3LCKKDR
SCHEMBL30962904 0.89 WEE1 (0.47) SIK1SIK2SIK3LCKKDR
SCHEMBL27313752 0.89 WEE1 (0.47) SIK1SIK2SIK3LCKKDR
SCHEMBL30962699 0.88 SRC (0.53) SIK1SIK2SIK3LCKKDR
SCHEMBL30962865 0.88 SIK1 (0.50) SIK1SIK2SIK3LCKKDR
SCHEMBL27313548 0.88 SIK1 (0.50) SIK1SIK2SIK3LCKKDR
SCHEMBL27313419 0.88 SRC (0.53) SIK1SIK2SIK3LCKKDR
SCHEMBL27313416 0.87 WEE1 (0.54) SIK1SIK2SIK3LCKKDR
SCHEMBL30962817 0.87 LCK (0.43) SIK1SIK2SIK3LCKKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642767-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS Acrivon Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
WO-2024145505-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS ACRIVON THERAPEUTICS, INC. (US) 2024-07-04 — — WO disclosed
Send feedback